![](https://www.diabetesnews.com/wp-content/uploads/2016/10/abbott-launches-freestyle-libre-d7d4ddb246-150x150.jpg)
The US Food and Drug Administration (FDA) approved Abbott’s FreeStyle Libre Pro on September 28 after more than a year of review. The professional continuous glucose monitoring (CGM) system will be made available to US healthcare providers later in Fall 2016.